Loading page content…
Loading page content…
| Source: | Contracts Finder |
| Buyer: | Medicines Discovery Catapult |
| Main Category: | Goods |
| Procurement Method: | Open procedure |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | £750,000 |
| Release Date: | 31 October 2022 |
| Application Deadline: |
Pipeline status
Not addedContract imported automatically · AI writes the response
Application Deadline
21 November 2022
Closed
Estimated Value
£750,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| 21 November 2022 |
| Procurement ID (OCID): | ocds-b5fd17-8acb7526-0445-49eb-8350-89dcad20785f |
| Notice Reference: | a3cf7e6e-fb74-4460-96f4-ceb3a05fd88a-585287 |
View Original Notice
Access the full notice on the official portal
The Advanced Technologies team at the Medicines Discovery Catapult (MDC) is looking to expand its current advanced microscopy facility to support both our own growing needs and provide the UK SME community access to advanced molecular and cellular imaging. MDC is aiming purchase a confocal High Content Screening (HCS) instrument based on an automated well-plate inverted microscope, together with confocal and widefield functionalities. It is crucial for the HCS system to be flexible and provide fast and high-resolution imaging of a wide range of experiments. The instrument should be configured to enable the use of different sample formats (2D and 3D cell models, tissue sections, fixed and live-cell) and experimental types (drug dose responses, live-cell kinetic studies, phenotypic screening, RNA scope), using a large variety of well-plate formats and a wide range of fluorophores. In addition, the HCS instrument must be supplied with a high-end solution for high content image analysis, visualization and handling. For more information, please follow this link - https://procontract.due-north.com/Advert?advertId=3e1c3152-f658-ed11-811b-9f38301b3091